PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
17-Nov-2023 Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX Minoryx
17-Nov-2023 Alfa Chemistry Excels in mRNA Vaccine Development, Production, Optimization, and Quality Control Alfa Chemistry
17-Nov-2023 CD Formulation Introduces Powder Flowability Testing to Maximize Tablet Performance CD Formulation
16-Nov-2023 Tessellate BIO, an Emerging Precision Oncology Company Announces the Appointment of World-Leading Scientists to its Scientific Advisory Board Tessellate BIO
16-Nov-2023 Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors Myricx Bio
16-Nov-2023 OMass Therapeutics expands leadership team with the appointment of Melissa Faris as Chief Business Officer OMass Therapeutics
16-Nov-2023 CD Formulation Provides Efficient Strategies to Develop and Optimize Microspheres & Microneedles CD Formulation
16-Nov-2023 Empowering Chemical Research: Alfa Chemistry Debuts Automated Synthesis Solutions Alfa Chemistry
15-Nov-2023 Amerigo Scientific Releases Automated Liquid Handling Equipment to Modernize Pipetting Workflow Amerigo Scientific
14-Nov-2023 Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria Glox Therapeutics
14-Nov-2023 The Revolutionary Era of Liquid Biopsy: A Non-Invasive Approach to Precision Medicine Roots Analysis
13-Nov-2023 IO Biotech Announces 2023 Third Quarter Results IO Biotech
13-Nov-2023 IO Biotech Appoints Helen Collins, MD, to its Board of Directors IO Biotech
13-Nov-2023 Resolution Therapeutics’ founders present clinical proof-of-concept for macrophage cell therapy in end-stage liver disease at AASLD Resolution Therapeutics Limited
13-Nov-2023 Oxolife Appoints International Fertility Experts to its Scientific Advisory Board Oxolife
13-Nov-2023 Press release: Xsphera Biosciences and NEX-I Collaborate to Advance Oncology Drug Research Xsphera Biosciences
10-Nov-2023 IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma IO Biotech
09-Nov-2023 PHARMANOVIA CEO, JAMES BURT APPOINTED CHAIR OF MEDICINES FOR EUROPE’S VALUE ADDED MEDICINES (VAM) SECTOR GROUP Pharmanovia
09-Nov-2023 Yourgene Health and Laboriad Launch Non-invasive Prenatal Testing in Morocco Yourgene Health
07-Nov-2023 Futura expands partnership with M8 Pharmaceuticals for remainder of Central and South American region Futura Medical plc